Clinical Trial Update: Calcium Folinate Treatment of Spastic Paraplegia 56 [EARLY_Phase 1]

View source ↗

Summary

This early-phase 1 clinical trial is evaluating calcium folinate for Hereditary Spastic Paraplegia and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Spastic Paraplegia

Drugs mentioned

• Calcium folinate (calcium folinate)

Snippet

Sponsor: Shanghai 6th People's Hospital | Conditions: Hereditary Spastic Paraplegia | EARLY_Phase 1 | Status: RECRUITING